Literature DB >> 3198064

Lipid metabolism in lipoatrophic diabetes.

G Enzi1, M Digito, G Baldo-Enzi, L Cominacini, G Dodi, R Carraro, F Zurlo.   

Abstract

Some aspects of lipid metabolism were studied in 4 patients with a congenital lipoatrophic diabetes (LAD) associated to a type IV hyperlipoproteinemia. The analysis of lipoprotein composition, expressed as mg/dl, demonstrates a significant increase of VLDL mass and a significant reduction of HDL mass. The analysis of lipoprotein composition, expressed as per cent of total mass demonstrates an increase of the triglyceride content in all fractions and a significant reduction of the cholesterol and phospholipid content in HDL2 particles. Apo C-II, C-III0, C-III1 and C-III2 levels in lipoprotein fractions were normal in LAD patients. Lipoprotein lipase activity in omental adipose tissue, collected during laparoscopy in one patient was undetectable. The serum of this patient did not fully activate the lipoprotein lipase eluted from normal adipose tissue. In all patients the adipose tissue lipoprotein lipase activity in post-heparin plasma was blunted or near absent. Thus a reduced peripheral clearance of triglyceride-rich lipoprotein could be an important determinant of lipoprotein abnormalities in lipoatrophic diabetes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198064     DOI: 10.1055/s-2007-1010891

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.

Authors:  Ranganath Muniyappa; Brent S Abel; Asha Asthana; Mary F Walter; Elaine K Cochran; Alan T Remaley; Monica C Skarulis; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Lipidol       Date:  2017-02-24       Impact factor: 4.766

Review 2.  Congenital lipodystrophies and dyslipidemias.

Authors:  Xavier Prieur; Cedric Le May; Jocelyne Magré; Bertrand Cariou
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

3.  Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.

Authors:  Marissa Lightbourne; Anna Wolska; Brent S Abel; Kristina I Rother; Mary Walter; Yevgeniya Kushchayeva; Sungyoung Auh; Robert D Shamburek; Alan T Remaley; Ranganath Muniyappa; Rebecca J Brown
Journal:  J Endocr Soc       Date:  2020-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.